INSERM U1119, Biopathology of Myelin, Neuroprotection and Therapeutic Strategy (BMNST Lab), Labex Medalis, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Pôle API, Ecole Supérieure de Biotechnologie, 300 Boulevard Sébastien Brant, 67412, Illkirch, France.
Cell Mol Life Sci. 2021 Jul;78(13):5257-5273. doi: 10.1007/s00018-021-03852-4. Epub 2021 May 21.
In demyelinated lesions, astrocytes, activated microglia and infiltrating macrophages secrete several factors regulating oligodendrocyte precursor cells' behaviour. What appears to be the initiation of an intrinsic mechanism of myelin repair is only leading to partial recovery and inefficient remyelination, a process worsening over the course of the disease. This failure is largely due to the concomitant accumulation of inhibitory cues in and around the lesion sites opposing to growth promoting factors. Here starts a complex game of interactions between the signalling pathways controlling oligodendrocytes migration or differentiation. Receptors of positive or negative cues are modulating Ras, PI3K or RhoGTPases pathways acting on oligodendrocyte cytoskeleton remodelling. From the description of this intricate signalling network, this review addresses the extent to which the modulation of the global response to inhibitory cues may pave the route towards novel therapeutic approaches for myelin repair.
在脱髓鞘病变中,星形胶质细胞、活化的小胶质细胞和浸润的巨噬细胞分泌几种调节少突胶质前体细胞行为的因子。似乎是髓鞘修复的内在机制的启动,只会导致部分恢复和低效的髓鞘再生,随着疾病的发展,这个过程会恶化。这种失败在很大程度上是由于在病变部位及其周围同时积累了抑制性信号,这些信号与促进生长的因子相对立。这就开始了一个控制少突胶质细胞迁移或分化的信号通路之间复杂的相互作用游戏。正或负信号的受体调节 Ras、PI3K 或 RhoGTPases 通路,作用于少突胶质细胞细胞骨架重塑。从这个错综复杂的信号网络的描述中,本综述探讨了调节对抑制性信号的整体反应的程度,这可能为髓鞘修复的新治疗方法铺平道路。